In ₹ Crore except Per Share 12 Months Ending | Q2 FY24 30/09/2023 | Q3 FY24 31/12/2023 | Q4 FY24 31/03/2024 | Q1 FY25 30/06/2024 | Q2 FY25 30/09/2024 | Q3 FY25 31/12/2024 | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 38.3 | 45.4 | 46.6 | 51.1 | 54.1 | 53.4 | 56.5 | 59.4 | 63.7 | 64.2 | 68.8 | 70.0 | |
| Other Income | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.1 | 0.2 | 0.3 | 0.4 | 0.4 | |
| Total Income | 38.5 | 45.6 | 46.9 | 51.4 | 54.3 | 53.7 | 56.7 | 59.6 | 63.8 | 64.4 | 69.2 | 70.3 | |
| Expenses | |||||||||||||
| + Employee Benefit Expense | 5.2 | 6.4 | 5.5 | 6.2 | 6.4 | 7.0 | 8.3 | 7.6 | 8.0 | 8.7 | 8.5 | 8.6 | |
| + Finance Costs | 8.9 | 11.1 | 13.5 | 14.3 | 15.5 | 17.2 | 17.9 | 18.2 | 20.8 | 21.8 | 22.8 | 23.7 | |
| + Depreciation & Amortisation | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | |
| + Other Expenses | 2.2 | 2.7 | 2.9 | 2.1 | 3.0 | 3.2 | 4.0 | 3.2 | 3.6 | 4.1 | 3.6 | 4.8 | |
| Total Expenses | 18.3 | 21.9 | 23.5 | 26.7 | 29.6 | 31.1 | 31.7 | 32.0 | 35.0 | 38.9 | 38.8 | 40.6 | |
| EBITDA | 29.3 | 35.0 | 36.9 | 39.0 | 40.5 | 39.9 | 43.2 | 46.1 | 50.0 | 47.5 | 53.3 | 53.6 | |
| EBIT | 28.9 | 34.6 | 36.6 | 38.6 | 40.0 | 39.4 | 42.7 | 45.7 | 49.5 | 47.0 | 52.8 | 53.0 | |
| Profit | |||||||||||||
| PBT before Exceptional Items | 20.3 | 23.8 | 23.4 | 24.7 | 24.7 | 22.6 | 25.0 | 27.6 | 28.9 | 25.5 | 30.4 | 29.7 | |
| + Exceptional Items | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | 0.0 | |
| Pretax Income | 20.3 | 23.8 | 23.4 | 24.7 | 24.7 | 22.6 | 25.0 | 27.6 | 28.9 | 25.5 | 30.2 | 29.7 | |
| + Current Tax | 5.4 | 6.8 | 5.2 | 6.3 | 6.7 | 5.4 | 6.4 | 7.1 | 7.5 | 7.0 | 8.1 | 7.9 | |
| + Deferred Tax | 0.0 | 0.3 | -0.4 | -0.2 | 0.2 | 0.3 | -0.4 | -0.8 | -3.1 | -2.4 | 2.7 | -0.3 | |
| Tax Expense | 5.4 | 7.0 | 4.8 | 6.2 | 6.9 | 5.8 | 6.0 | 6.3 | 4.4 | 4.6 | 10.8 | 7.6 | |
| Net Income | 14.8 | 16.7 | 18.6 | 18.5 | 17.9 | 16.8 | 19.0 | 21.3 | 24.5 | 20.9 | 19.4 | 22.1 | |
| + Net Income — Continuing Ops | 14.8 | 16.7 | 18.6 | 18.5 | 17.9 | 16.8 | 19.0 | 21.3 | 24.5 | 20.9 | 19.4 | 22.1 | |
| + Other Comprehensive Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.0 | 0.0 | 0.0 | 0.0 | -0.1 | -0.0 | |
| Total Comprehensive Income | 14.8 | 16.7 | 18.6 | 18.5 | 17.9 | 16.8 | 19.0 | 21.3 | 24.5 | 20.9 | 19.4 | 22.1 | |
| Per Share | |||||||||||||
| Basic EPS | 7.04 | 7.34 | 8.15 | 8.12 | 7.84 | 7.36 | 8.32 | 9.36 | 10.73 | 9.18 | 8.52 | 9.72 | |
| Diluted EPS | 7.01 | 7.32 | 8.13 | 8.03 | 7.75 | 7.28 | 8.25 | 9.28 | 10.65 | 9.79 | 8.46 | 9.64 | |
| Revenue Detail — as filed | |||||||||||||
| + Fees & Commission Income | — | 5.6 | 1.5 | 3.7 | — | 2.1 | 2.5 | 2.5 | 2.5 | 1.9 | 2.9 | 2.8 | |
| Expense Detail — as filed | |||||||||||||
| + Fees & Commission Expense | — | 0.0 | 0.1 | 0.1 | — | 0.2 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | |
| + Impairment on Financial Instruments | — | 1.3 | 1.2 | 3.6 | — | 3.2 | 1.0 | 2.4 | 1.8 | 3.8 | 3.3 | 2.8 | |
| Other Comprehensive Income — detail | |||||||||||||
| + Other Comprehensive Income | — | 0.0 | 0.0 | 0.0 | — | 0.0 | -0.0 | 0.0 | — | — | -0.1 | -0.0 | |
| + Items NOT to be Reclassified to P&L | — | — | — | — | — | — | — | — | — | — | -0.1 | — | |
| + Tax on Items NOT to be Reclassified | — | — | — | — | — | — | 0.0 | 0.0 | — | — | -0.0 | 0.0 | |
| + Tax on Items to be Reclassified | — | — | — | — | — | — | 0.0 | 0.0 | — | — | 0.0 | 0.0 | |
| Per Share — as-filed variants | |||||||||||||
| Basic EPS — Continuing Operations | 7.04 | 7.34 | 8.15 | 8.12 | 7.84 | 7.36 | 8.32 | 9.36 | 10.73 | 9.18 | 8.52 | 9.72 | |
| Diluted EPS — Continuing Operations | 7.01 | 7.32 | 8.13 | 8.03 | 7.75 | 7.28 | 8.25 | 9.28 | 10.65 | 9.79 | 8.46 | 9.64 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||||||||||||
| Related-party Transactions — During the Period | — | — | — | — | — | — | 55.9 | — | 40.2 | — | 52.0 | — | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | |||||||||||||
| Gross Profit | 38.3 | 45.4 | 46.6 | 51.1 | 54.1 | 53.4 | 56.5 | 59.4 | 63.7 | 64.2 | 68.8 | 70.0 | |
| Gross Margin % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
| Adjusted (ex-Exceptional Items) — derived | |||||||||||||
| Pretax Income (Adjusted, as filed) | 20.3 | 23.8 | 23.4 | 24.7 | 24.7 | 22.6 | 25.0 | 27.6 | 28.9 | 25.5 | 30.4 | 29.7 | |
| − Exceptional Items (reconciliation) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | 0.0 | |
| Net Income Adj (tax-effected) | 14.8 | 16.7 | 18.6 | 18.5 | 17.9 | 16.8 | 19.0 | 21.3 | 24.5 | 20.9 | 19.5 | 22.1 | |
| EPS Adj | 7.04 | 7.34 | 8.15 | 8.12 | 7.84 | 7.36 | 8.32 | 9.36 | 10.73 | 9.18 | 8.57 | 9.72 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||||||||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |
| Filed Debt Equity | — | — | — | 0.00 | 0.00 | 0.00 | 0.01 | — | 0.01 | 0.02 | 0.01 | 0.01 | |
| Interest Earned | — | 39.5 | 44.6 | 46.8 | — | 50.3 | 53.0 | 56.0 | 59.2 | 61.3 | 65.4 | 65.9 | |
| Paid Up Equity Capital | 22.4 | 22.4 | 22.4 | 22.5 | 22.5 | 22.5 | 22.5 | 22.5 | 22.5 | 22.5 | 22.5 | 22.5 | |